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Cochrane is an international network that produces and updates new knowledge through 
systematic reviews for the health sector. Knowledge is a shared resource, and can be viewed as a 
commons. As Cochrane has been in existence for 25 years, we used Elinor Ostrom’s theory of the 
commons and Institutional Analysis and Development Framework to appraise the organisation. 
Our aim was to provide insight into one particular knowledge commons, and to reflect on 
how this analysis may help Cochrane and its funders improve their strategy and development. 
An assessment of Cochrane product showed extensive production of systematic reviews, although 
assuring consistent quality of these reviews is an enduring challenge; there is some restriction of 
access to the reviews, open access is not yet implemented; and, while permanence of the record is 
an emerging problem, it has not yet been widely discussed.  The assessment of the process showed 
that the resource, community, and rules-in-use are complex, vary between different groups within 
Cochrane, and are not well understood. Many of the rules have been informal, and the underlying ethos 
of volunteerism where reviews get done are important features and constraints to the organisation. 
Like all collective efforts, Cochrane is subject to collective action problems, particularly free-riding 
and variable commitment, and the under-production of public goods and internal processes, such 
as surveillance of product quality and procedures for transparent resolution of conflicts. 
key words Cochrane • knowledge commons • institutional analysis • Ostrom
Background
This paper reports on an institutional assessment of Cochrane (formerly known as 
the Cochrane Collaboration), an organisation whose mission is the production of 
up-to-date systematic reviews of the effects of health interventions produced using 
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standard procedures. It is unusual as an organisation as it was built from the bottom 
up: at its launch in 1993 it was entirely volunteers who were committed to producing 
the systematic reviews (Box 1). With over 7000 reviews published by 2017, Cochrane 
is an important producer of knowledge in health. 
The characteristic of knowledge as a shared resource has drawn scholars, the most 
notable of whom is Elinor Ostrom, to see it as a commons, the knowledge commons 
– a shared resource. With Cochrane now in existence for almost 25 years, we sought 
to examine how Ostrom’s conceptual approach and methods of analysis could apply 
to Cochrane. The objective of the work reported here was to explore whether this 
analysis provides insight: first, as an example of applying the knowledge commons 
to medical and public health knowledge; and second, in how Cochrane operates, to 
help the organisation and its funders reflect on this complex organisation to improve 
strategy and development over the next decade.
Ostrom built on her extensive work analysing the natural commons (Ostrom, 
1990) such as community-managed forests and irrigation systems, to propose a similar 
approach for analysis of the knowledge commons (Hess and Ostrom, 2011). Others, 
most notably Frischmann and colleagues, have modified and added to (Strandburg 
et al, 2014) the approach of Ostrom and Hess, arguing that the analogue to a natural 
commons is a culturally constructed commons, 
… environments for developing and distributing cultural and scientific 
knowledge through institutions that support pooling and sharing of 
knowledge in a managed way, much as a natural resource commons refers 
to the type of managed sharing environment for natural resources…. 
(Frischmann et al, 2014)
To carry out an assessment of Cochrane with this lens we used a framework that 
encompasses both the product (the systematic reviews) and the process (the workings 
of Cochrane). We use the Institutional Analysis and Development (IAD) framework 
proposed by Ostrom and her colleagues (Hess and Ostrom, 2011) and modified by 
Strandburg et al (2014) in their analysis of the Rare Diseases Clinical Network as a 
knowledge commons. 
In the first phase of our work, we considered Cochrane in relation to the knowledge 
commons’ literature and how the organisation maps on to theory. With this frame, 
we could then identify what was important to consider in a rapid evaluation of the 
knowledge produced; the institutional analysis surrounding its production; and the 
collective action problems that are recognised within knowledge commons.
What is Cochrane?
Launched in 1993, Cochrane has as its primary objective the production of up-to-date, 
reliable systematic reviews about the effects of healthcare to inform healthcare decisions 
and research priorities. Systematic reviews are now regarded as primary research: the 
critical appraisal identifies weaknesses and strengths in the original data not identified 
by referees and often only apparent when taken in the context of structured, systematic 
appraisal of other research asking a similar question; and the bringing together of different 
studies asking a similar question can generate new knowledge.
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The Cochrane Collaboration, formally launched in 1993 at the 1st Cochrane Colloquium 
in Oxford, was a response to a challenge to the medical profession 20 years earlier from 
Archie Cochrane (Cochrane, 1972) to provide better evidence for healthcare interventions. 
In 1995 Cochrane was registered as a Company and a Charity under English law and the 
Executive Office established. 
Cochrane’s ‘Strategy to 2020’ (Cochrane Collaboration, 2014) sets four goals and associates 
targets with each. The goals are to:
1 Produce evidence, principally through high-quality systematic reviews
2 Make evidence accessible and useful around the world
3 Advocate for evidence as the leading advocate for evidence-informed healthcare
4 Build an efficient and sustainable organisation 
At the centre of Cochrane are Cochrane Review Groups (CRGs) whose members prepare, 
maintain and update systematic reviews known as Cochrane Reviews (CR). Each group 
has an editorial base where a small team, led by a Coordinating Editor (CE), who has final 
sign-off authority for the product of the group, together with the Managing Editor (ME) 
and a Trials Search Coordinator (TSC), support the production of CRs. Authors propose 
topics for review, the protocol for which must be approved by the CE in dialogue with 
CRG Editors. This process takes into account reviews in other CRGs. In addition to CRGs, 
Cochrane also has Methods groups and Cochrane Centres that support authors and CRGs in 
geographic and linguistic areas. As of March 2017, there were 52 CRGs and representatives 
in 43 countries.
Cochrane developed rapidly during its first decade when its procedures and methods 
were developed. At this time, the approach of the central executive was hands-off, and 
allowed considerable variation between CRGs and the way they approached their task. 
The Executive Office was small (a total of five FTEs in 2002) with limited involvement 
in details of work programmes of individual CRGs. Concern about the quality of CRs has 
been a recurrent theme for Cochrane almost from the beginning. It continues today and 
is at the centre of current discussions.
The first full-time Chief Executive Officer (CEO) was appointed in 2003 and a publishing 
agreement with Wiley-Blackwell was put in place; a new agreement was signed in 2013. 
National governments purchase licences that provide free access at the point of use in 
Ireland, Australia, Finland, Norway and the United Kingdom, and in India. Free one-click 
access is available to all people living in low income countries (HINARI bands A and B). 
In 2014, a new CEO developed a strategic plan with the organisation, commenced a 
review of governance, and rebranded the Collaboration ‘Cochrane’, dropping the word 
Collaboration. By 2015 the Cochrane Central Executive had more than 50 full-time staff.
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Methods
The approach
Hess and Ostrom (2011) see knowledge as ‘all tangible ideas, information, and data in 
whatever form’. They also follow the division of knowledge into data-information-
knowledge. Data is ‘raw bits of information, information being organised data in 
context, and knowledge being the assimilation of information and understanding 
how to use it’. (2011, 8). Knowledge can be gained through experience or study, is 
cumulative (2011, 9), and must be passed from one individual to another to have 
public value (2011, 53). The cumulative and aggregative nature of knowledge means 
that storage of past knowledge, and access to the store, is critical. Following this 
approach, by producing systematic reviews Cochrane is engaged in the production of 
knowledge. Cochrane, a complex organisation that utilises resources held in common 
(common property resources), facilitates and promotes the production of knowledge. 
Analysis of outputs
Assessment of the output (systematic reviews) was made against the attributes set by 
Cochrane itself in its first strategic plan 2020 (Cochrane, 2009). We examined these 
in relation to four main parameters, three of which are from the strategic plan: the 
quantity produced; the quality, in terms of international expectations; and the access 
to the product, or if it is restricted in some way. The fourth, and final, aspect we 
examined was the permanence of the record – that is, that the product is permanently 
accessible, with little risk of it being destroyed or unavailable later. Although this is 
not in Cochrane’s strategy, it is critical to the long-term effectiveness of Cochrane 
(Waters, 2011). 
Institutional analysis
The Institutional Analysis and Development (IAD) framework was developed by 
Ostrom and colleagues as a diagnostic tool and as the basis for comparative institutional 
analysis of shared resources such as the Cochrane. Using the approach of Ostrom 
(2011), Cochrane can be seen as a common pool resource providing a flow of resource 
units derived from social and human capital and funds over time. Multiple individuals 
can use this resource, which renders it liable to exhaustion and degradation. To prevent 
exhaustion and depletion of the resource, access rights are held in trust by Cochrane, 
which assigns or appoints individuals to roles related to the organisation’s goals. The 
rules governing access and other activities convert the common pool resource to 
a common property resource owned by Cochrane, the primary product of which, 
systematic reviews, is, potentially, a public good. 
The IAD framework, as applied to Cochrane, is shown in Figure 1 – it consists of 
three main parts. First, the three vertically-aligned boxes on the left-hand side of the 
diagram draw attention to the role of three components:
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• The resource – comprising the social capital, the human capital, the infrastructure 
and the funds
• The community – comprising those who produce the reviews and infrastructure 
(methods and procedures used by Cochrane) as well as those who provide policy 
and utilize the final product
• The governance and the rules-in-use (those rules generally known and enforced), both 
formal and informal, which provide the basis for governance of the organisation. 
The process plays out in the action situation – the middle portion of the diagram is 
the general representation of an interaction between at least two individuals who 
meet to achieve a certain outcome. The decisions made depend on the information 
and knowledge available to the individuals, the control each has over their own 
decisions, and the net costs and benefits thought to be associated with the decision. 
Examples of action situations range from formal meetings of Cochrane, to meetings 
of authors working on systematic reviews. The action arena works in a context, which 
includes goals of the organisation, the funding climate, and alternative producers of 
systematic reviews. 
Cochrane is multi-level. The operational level is where reviews are prepared by 
authors; at the CRG level (referred to in institutional analysis as the collective-choice 
level) decisions that affect the operational level are made; and at the central level 
(referred to in institutional analysis as the constitutional level) decisions that affect 
the collective-choice level are made. The relationship between these levels means 
that Cochrane is also hierarchical – decisions at one level constrain actions that can 
be taken at the level below. 
The manner of interaction between the various individuals at each level affects 
whether the group will be successful in producing quality reviews and, when 
aggregated, the overall success or failure of Cochrane in producing systematic reviews, 
as well as in generation and utilisation of resources. The provision of information 
about these two forms of product requires feedback mechanisms, one which provides 
information about the quantity and quality of systematic reviews, and one about 
resources. 
Figure 1: Action situation for Cochrane
Source: Adapted from Ostrom and Hess [22]
Peter Heywood et al
6
Cochrane is an example of an entity whose infrastructure, resources, and rules 
facilitate and promote the production of knowledge, in this case systematic reviews 
which, provided they are widely accessible, have many of the characteristics of a 
public good. In other words, once they have been produced and released, use by 
one person does not prevent another person from using the review, and once the 
review is available to one person it is available to most. The ultimate contribution 
to knowledge by the systematic reviews also depends on their permanence and 
quality. This relationship between Cochrane, collective action, and knowledge – the 
knowledge commons – is shown in Figure 2. 
Voluntary groups working together require collective action, but this has its problems 
(Figure 2). Individuals participating in these groups experience both incentives and 
disincentives to act. Depending on their relative influence, the balance of incentives 
may lead some people to conclude that they can free-ride, obtain the benefits of the 
group without paying the costs of making a significant contribution. 
Thus, our evaluation is framed from Ostrom’s theory and the knowledge commons 
literature. We identified three main areas for our appraisal:
1. The knowledge produced, in relation to quantity, quality, access and permanence
2. The institution, in relation to the product, in relation to resources used, 
community, governance / rules in use, the setting and mode of interaction 
between participants, and feedback (Figure 1)
3. Collective action problems found with ‘commons’, including free-riding, 
commitment, supply of new institutions (rules and procedures), monitoring and 
feedback, and compliance and dispute resolution (Figure 2).
Figure 2: The Cochrane Collaboration as a knowledge commons
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Data collection
Our sources of data were existing publicly available documentation and interviews 
with key informants. Sources of information used for each framework element are 
shown in Table 1. Documentary sources included published literature, online sources, 
review of the Cochrane Database of Systematic Reviews, the Cochrane Collaboration 
Strategic Review, and minutes of CCSG (Cochrane Collaboration Steering Group). 
Data were collected and discussed by the review team daily, and interviews done 
with at least two members of the team participating.
We interviewed 15 key informants drawn from a range of roles in Cochrane. These 
included those involved in the initiation of the collaboration, the current director of 
the UK Cochrane Centre, the current CEO and Coordinating Editors, CEU staff, a 
Managing Editor, the senior executive of the National Institute of Health Research 
(NIHR) with responsibility for the NHS funding of Cochrane, and authors attending a 
Cochrane meeting in Manchester. We also had correspondence with a member of the 
publisher’s staff about the number of reviews produced and the extent to which access 
to the reviews was open (see Table 1). All interviewees were employees of Cochrane 
or senior administrators, who we judged were not vulnerable and thus requiring 
ethical committee approval. Interviewees were briefed on the aims of the study and 
the purposes of the interviews were fully explained to each participant. We outlined 
that the work was research aiming to apply Ostrom’s IAD framework to an example of 
a knowledge commons, and that this would be submitted for publication; and we also 
intended to identify useful insights that might help Cochrane in developing its long-
term strategy, to be communicated to Cochrane and the participants at presentations 
at Cochrane meetings and through publication. We also assured participants that the 
results would be presented in a way that would preclude their identification. Having 
explained these, we then sought and obtained verbal consent. The content of these 
discussions was initially guided by topic guides based on the framework, preliminary 
reading and discussion, and our own experience. Interviewees were encouraged to 
raise items beyond these guides if they wished, and most did so. We had multiple 
meetings with some interviewees, with the express purpose of clarifying information 
presented earlier and to discuss points emerging from our analysis. Sometimes these 
exchanges were continued by phone and email.
Review of interview notes and discussion after each interview meant that analysis 
was ongoing with constant analysis between interviews. Concurrently, we reviewed 
documents on various aspects of Cochrane. Thus, information from interviewees, 
currently in a range of roles as well as those whose roles had changed over time, 
together with information and analysis based on documents from a range of sources, 
allowed us to check information, fill gaps, elaborate on emerging themes, and 
triangulate against phenomena and issues from several perspectives. The authors 
discussed the analysis and interpretation iteratively and reached consensus about 
judgements within the framework derived for the analysis.
Within each component and area of the framework, analysis was continuous and 
inductive. As findings were placed in the framework, where indicated we followed 
up with further document analysis and, where possible, interviews and emails.
The research was carried out between March and June 2015, and updated in April 
2017.
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Some of the strengths of the analysis were being able to draw on sources across the 
organisation for all elements of the framework, and from individuals with a long 
institutional memory at a senior level. Some of the limitations were that the number 
of people interviewed was limited, and we depended extensively on publicly available 
documents. 
Reflexivity 
We were aware that engagement of two of the team in Cochrane was a strength, 
but needed careful reflection and attention as to how we collected, analysed and 
interpreted data. We discussed this as a team as we developed our methods. 
One of us (PH) had limited previous Cochrane involvement, was the team leader, 
and specialist on institutional analysis (IA) and the knowledge commons. PH was a 
team member, along with PG, for one systematic review which used Cochrane-like 
methods but was published outside the Cochrane system. He had no other involvement 
with Cochrane until this study, but was recently involved in an institutional analysis 
of the HIV/AIDS control programme in Indonesia. Building on this earlier work 
he initiated this study of Cochrane as an example of a successful organisation built 
from the bottom up with a strong participatory approach. The effect of his limited 
previous Cochrane experience meant that, in contrast to PG, he brought to the 
analysis a different and non-Cochrane perspective. 
Interviews were led by PH in partnership with PG, who has been involved in 
Cochrane since its inception as an author, and as a CE for systematic reviews covering 
a wide range of topics; he had also been a member of the Cochrane Co-ordinating 
Editors Executive. Whilst his familiarity with Cochrane facilitated appointments, it 
was important to minimise the extent to which this involvement adversely influenced 
judgments about the analysis. Discussions after each interview explicitly addressed this 
issue. The third author, AMS, is currently working as part of Cochrane, and thus has 
detailed knowledge of current processes, procedures and debates; she helped source 
materials, analysed data and participated in the discussions and analysis.
At the outset of the review all three authors believed that evidence synthesis is a 
useful and important scientific endeavour.
Table 1: Sources of information
IAD category Aspects assessed Source of information
Product Quantity, quality, access, 
permanence
Cochrane records, NHS, minutes of meetings, 
published papers and reports, discussions with 
NHS,
Cochrane documents, discussions with Wiley, 
published literature
Process Resource, community,
rules-in-use
CRGs, authors, managing editors, and other key 
informants
Collective 
Action problems
Free-riding, monitoring, dispute 
resolution
Editors, authors, newsletters, articles in journals, 
blogs, key informants
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Results
The product
In presenting the findings we focus on the main Cochrane products: new reviews and 
updates of previous reviews. We concentrate on the four critical aspects of Cochrane 
addressed in the first section – quantity, quality, access, and permanence (Figure 2 
and Annex 1). 
Quantity 
The quantity of new reviews has been carefully monitored since 1995 through 
custom software. Interrogation of this custom software (Archie) in December 2016 
shows that over 7000 reviews have been published since this monitoring began. The 
number of new reviews published each year increased rapidly in the early years and 
is now consistently over 400 (Figure 3). In the last 15 years, approximately two-thirds 
of these new reviews have been produced through CRGs under subsidy from the 
NIHR (authors’ analysis of information supplied by NIHR). 
There is considerable variation between the 52 CRGs in the number of reviews 
produced since Cochrane commenced. The top 15 CRGs (by total number of reviews 
since 1993) have produced half of all new reviews. Two CRGs, those for pregnancy 
and childbirth, and neonates, have produced one-tenth of all reviews. 
Figure 3 Cochrane Library, number of reviews, all groups, 1995–2016
Source: Authors' calculations using data derived from Archie, (accessed 13/05/2015).
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Quality
Variation in quality of reviews, and what to do about it, has been a topic of discussion 
within Cochrane almost since the first review was produced: for example, the topic 
was discussed at the 1996 CCSG meeting in Adelaide and a paper to address the 
issue commissioned. By the year 2000 one of the advisory groups reporting to the 
CCSG was a Quality Advisory Group. Discussion of quality continued at subsequent 
CCSG meetings and in 2008, under continuing pressure from Co-ordinating Editors, 
a proposal to appoint an Editor in Chief (EIC), with a primary aim of improving 
quality, was accepted along with a proposal for development of explicit training 
activities to support authors. An Editor in Chief (EC) was appointed in 2009, and a 
Board of Co-ordinating Editors to work with the holder of this new position was 
created at the same time. 
Amongst the early attempts to assess the quality of Cochrane reviews was the work 
of Olsen et al (2001), who assessed the quality of a sample of 53 Cochrane reviews 
published in 1998. Almost one-third of reviews had major problems which included 
biased conclusions and problems with methods. Smith et al (2015) examined 788 
reviews published in 2007 and 2011 – 37% of pre-specified outcomes were not 
reported. In the light of the enduring quality discussions, the EIC worked with 
Co-ordinating Editors to establish the ‘methodological expectations of Cochrane 
intervention reviews (MECIR)’, a collection of recommendations and mandatory 
elements for the conduct and reporting of new Cochrane reviews. In 2013, the Central 
Editorial Unit (CEU) (2015) started screening all new and updated reviews submitted 
for publication. They screened a total of 56 reviews published in August 2013 and 
August 2014 – the proportion of reviews judged to be fully or partially compliant 
with all quality items was 18% in 2013 and 64% in 2014. The Central Editorial Unit 
continues to screen projects to assess quality, and this is now seen as the first stage of 
developing a more systematic approach to quality assurance (Central Editorial Unit, 
2015). Debates continue as to whether this is improving quality overall, or simply 
catching reviews that are sub-standard. However, the results are apparently not made 
public, and how the analysis by CRG is shared with the CCSG (now the Governing 
Board), and what decisions arise from any discussions at this level, is not clear. In the 
meantime, anecdotal evidence indicates that the variation in quality persists and that 
there is considerable difference in quality between CRGs (Misso et al, 2017). 
Access 
In both the first and second Strategic Plans of Cochrane the second goal was to 
promote access to the reviews. This goal is at variance with what happens in practice: 
under commercial publishing, access has generally always been restricted to those 
individuals, organisations or countries that paid an annual licence, up to 2013. 
More open access (OA) only became possible in 2013. The current agreement 
with Wiley allows for either Green OA (12 months after publication) or Gold OA 
(immediately on publication after payment of an article processing charge (APC) by 
the authors of US $5,000 for the initial publication and a slightly reduced fee each 
time the review is updated). Important points of the agreement are as follows:
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• All reviews and updates published before February 2013 are behind a paywall, 
or are limited to users with access to a country or institutional licence
• Reviews and updates published after 1 February 2013 are available immediately 
if Gold OA and after 12 months if Green OA
• Earlier versions of reviews are not available under OA even when an update is 
available via Gold OA
• In countries with annual licences (UK, Australia, Canada, NZ, India) access is 
free at source
• In low- and middle-income HINARI A and HINARI B countries, and those 
in the Caribbean and Latin America region covered by BIREME agreements, 
access was free to anyone with an IP address from that country up to January 
2016. This free access can be reviewed by the publisher, and therefore potentially 
removed, at any time
• For Gold OA, authors sign a licence for publication form which allows for 
immediate unrestricted access and non-commercial reuse provided the original 
article is cited (CC-BY-NC or CC-BY-NC-ND licence) , details of which are 
shown in Creative Commons (2015) 
This new agreement took effect in February 2013. In the year 2013–2014, four Gold 
OA reviews were published. The Green OA started in February 2013 with a 12-month 
embargo on OA access. Therefore, there were no Green OA reviews available for 
free until February 2014. In the year 2014–2015, a total of 421 new reviews were 
published, with 411 of these using the Green OA method, and only 10 using Gold 
OA. Similarly, of 498 review updates over that time, 492 were Green OA, and only 
6 were Gold OA. For the period 2015–2016, 426 out of 439 new reviews and 459 
out of 470 review updates were Green OA (13 new reviews and 11 review updates 
as Gold OA).
Thus, access is limited in three ways. First, those in countries without an annual 
agreement – most of the world – either have no access, access to only a limited 
subset of reviews, or access is only possible through non-profit organisations such 
as universities and hospitals, in effect limiting access to individuals employed by or 
associated with those organisations. Second, access to all earlier versions of reviews is 
behind a paywall, effectively limiting access to the previous record. Third, future use 
of the content of reviews is limited – while Green OA reviews can be deposited on 
personal or institutional repositories after the embargo period, the licence does not 
allow for further distribution or reuse of the data by others. Gold OA does make use 
of a Creative Commons Licence agreement after payment of an APC, although this is 
restricted to the NC and NC-ND versions of CC-BY agreements. The overall effect 
of these restrictions is that what was a public good has now been partly enclosed, 
limiting its free availability (see Chan and Costa, 2005), the overall result of these 
restrictions is that what was a public good has now been partly enclosed, limiting its 
free availability to many and turning the reviews into a commodity available to those in 
high-income countries and, should they wish, to high-income groups in low-income 
countries; and limiting further commercial use for translation and technologies such 
as data mining and semantic tagging.
While the APC required by Wiley is in line with other large hybrid OA journals such 
as The Lancet or BMJ, this fee is considerably more expensive than the APC required by 
exclusively OA publishers (for example, Public Library of Science). Although there is 
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a waiver system in place when the first author is from an HINARI-A or HINARI-B 
country, this again limits the use of the Gold OA option to those in high-income 
countries, and within high-income countries, limits use to those authors or CRGs 
who have access to funds set aside for such dissemination strategies.
Permanence
There are three main aspects to permanence. The first relates to the control over 
review content which rests with the CRGs who can alter reviews. Whilst major 
changes should result in the review having a new edition version, a new date and a 
new citation on MEDLINE, smaller corrections can be made at the discretion of the 
CRG and not recorded anywhere. However, there are examples of quite large changes 
to findings being made, and the CRG simply overwriting the previous published 
version – thus destroying public access to the earlier version. In addition, review groups 
currently have the discretion to withdraw reviews, for reasons set out in the Cochrane 
Editorial and Publishing Policy Resource, including where the review is substantially 
out of date, or where there has been a breach of the commercial sponsorship policy.1 
When a review is withdrawn, it is flagged as such on the Cochrane Library and only 
the title, coversheet, and reason for withdrawal will be published; the MEDLINE 
abstract remains, but with the prefix of ‘withdrawn’. Where there are serious errors 
in a review, a separate policy for withdrawing the review in consultation with the 
EIC is now in place.2
The second aspect relates to publication. In the period 1994–1998, when new 
editions of reviews were produced they replaced the older versions and the previous 
record was lost from the published product, although archives of the CDs published 
quarterly are held at the UK Cochrane Centre. Now the Cochrane Library archives 
old editions and they are available online, but behind a paywall. Whilst this has assisted 
with overcoming the almost automatic impermanence of the previous system, access 
to the permanent record is now limited.
The third aspect relates to the publishing contract with Wiley. Whilst a print journal 
can remain as a permanent record once printed on paper, continued access to the 
Cochrane Library is dependent on the contractual commitment by the publisher, 
and assumes the publisher remains in business. Grey areas include the commitment to 
providing access should the publisher change hands. There is currently no agreement 
with a third party regarding permanence of the Cochrane Library should the publisher 
fail. 
As the Green OA model gains traction, and more reviews in the Cochrane Library 
fall within this grouping, authors will retain the right to deposit their reviews in 
institutional or other repositories after the embargo period. Cochrane reviews 
published before February 2013 cannot be deposited in this manner; those published 
between February 2013 and September 2016 can be deposited by the lead author; 
and those published after 21 September 2016 will automatically be deposited in 
PubMed Central (PMC) 12 months after publication, although it remains the author’s 
responsibility to authorise this. When Gold OA reviews are updated, failure to continue 
with the Gold OA publishing model (that is, to not pay the APC and to have the 
review embargoed for 12 months before depositing in PMC), results in the risk that 
more people will have access to the ‘old’, OA version of the review than to the up 
to date review. These rapidly changing developments raise new complexities with 
version control and permanence with reviews that are updated, and the implications 
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of this have not been fully thought through. Overall, the permanence of the record 
is a key consideration in terms of the knowledge commons, but much more thought 
is required to cover the myriad of bases to help assure this within Cochrane.
The process
The general mode of operation in producing reviews has been to place responsibility 
for implementing editorial policies contained in the Cochrane Handbook (and more 
recently within MECIR standards) with the CRGs and, therefore, with the Co-
ordinating Editors and Managing Editors. This devolution meant that each CRG 
developed its own approach within a broad, overall understanding of Cochrane’s 
mission, objectives and processes. The result was considerable, largely undocumented, 
variation between the CRGs in processes and quality of output. 
Within the CRGs, and given the role played by the Co-ordinating Editors, decisions 
on contentious issues are likely to be made by the leadership. At the same time, daily 
operational decisions are usually made by the Managing Editor, Editors and the 
authors. The distributed nature of Cochrane means that there is little incentive for 
CRGs to work together. 
What was essentially an internal Strategic Review of Cochrane, published in 
2009 (Cochrane, 2009), begins by recognising that most of the contributors are 
not employed by Cochrane – these are the often mentioned ‘volunteers’ of the 
Collaboration; and that the structure of the collaboration is highly decentralised 
with a high degree of autonomy for each group. Because of this, and the variety of 
settings in which Cochrane groups fund and organise themselves, there is necessarily 
a need for flexibility in the way the various groups operate. The review recognised 
that the environment in which Cochrane operated was changing, the most important 
factors of which were: 
• Dramatic increase in number of producers of non-Cochrane systematic reviews
• OA publishing model 
• Increased workload with success of Cochrane
• Increased complexity of problems under review and the methods being used
Assessment against IAD framework
We examined the current function of the common property resource (CPR) by 
the types of information identified from use of the IAD framework. Details of these 
results are shown in Annex 1, which also shows a brief description of each variable. 
Where there have been changes in the 20 years of Cochrane we show these for the 
first and second decade separately. Overall, these results show that:
• Resources are a complex mix of social capital, human capital and funds – their 
relative importance is not well understood and may vary between groups
• Of the three community groups, the most critical for assuring outputs and least 
understood are the various 52 collaborative review groups. Little is in the public 
domain as to what is the same about them, what is different on comparative 
quality, variation in resources, or measures of their efficiency 
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• Rules / governance – the formal and informal rules reflect the distributed nature 
of Cochrane and allow considerable variation between groups in the way they 
operate; this variation is likely to be a source of both strength and weakness but 
neither is well understood. Some are informal, such as not rejecting any review, 
despite how poor the quality; others are more formal, such as how recent a search 
should have been carried out on a new review
• Action situation – whilst the underlying ethos is volunteerism the motivation 
of individuals varies from altruistic to selfish; the factors which affect motivation 
are not well understood, and increasingly grant funding and salaries are attached 
to review production 
• Feedback – there is no attempt to monitor quality on an ongoing and detailed 
basis. There is little feedback to groups on the quality of their work and almost 
none of this feedback is public
Assessment of collective action problems 
This is the rectangle at the base of Figure 2. The CRGS produce the systematic 
reviews which are the acknowledged output for which Cochrane is well known. The 
initial members of Cochrane formed the CRGs, agreed on basic common procedures, 
and produced the reviews. Many were highly skilled in their individual fields and 
committed to rising to the challenge set by Archie Cochrane. In carrying out this work 
members received personal gratification as well as professional acknowledgement from 
their peers. Given that most members were in academia or closely allied pursuits, such 
as the civil service, there was an ongoing negotiation between members and editors 
as to the input required and the way in which that input would be acknowledged, 
especially authorship of reviews which is seen in academia as research output. 
The distributed nature of Cochrane initially meant that there was a small central 
unit, whose task was limited and essentially administrative, and that the CRGs were 
relatively autonomous; they were, however, expected to prepare reviews using the 
agreed overall set of procedures, and to present their product in a uniform framework. 
Within this framework, CRGs operate quite independently of one another and of 
the central executive. Consequently, there is variation in the output of the groups, 
both in quantity and quality. Although there has always been much discussion of 
quality, systematic monitoring of it has only recently been put in place. At the same 
time, other groups produced new procedures, work that was particularly intense in 
the first years of Cochrane. 
Commitment of members to the cause varies, as does their motivation. Some 
continue to be driven by the challenge from Archie Cochrane, others are driven by 
the knowledge that joint authorship on another Cochrane review will bolster their 
publication list, with all the possible combinations in between. Some, rising to the 
challenge from Cochrane, are not concerned with recognition, others see opportunities 
for recognition that requires little input.
As these variations play out it is assumed that individuals are driven by professional 
standards and that, whilst quality may vary, overall it would be at a high level. Thus, 
little attention was given to monitoring quality, even though it was a persistent 
topic of discussion within Cochrane. There has been only limited discussion of the 
need for new rules, procedures and methods as the context within which Cochrane 
operates changed. 
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This decentralised structure and minimal supervision meant that differences 
between CRGs and with the Central Executive were often avoided, sometimes 
ignored, and on the limited occasions on which they were addressed, dealt with 
in non-transparent ways. This situation persists today. There is no accepted public 
mechanism for articulating disputes and searching for their resolution. 
More recently the role of the CEU has changed, moving from a staff of five in 2002 
to over 50 now, a ten-fold increase in staff numbers. There has been little explicit 
discussion of the implications of this increase in central resources for the relative roles 
of the CEU versus the CRGs and other groups, essentially a discussion between the 
central salaried staff of Cochrane and the volunteers, those responsible for the reviews 
on which the organisation’s reputation is based. 
Because Cochrane is voluntary, self-organised and produces public goods (in other 
words, it is difficult to exclude people from obtaining access to the good) there are 
considerable opportunities for free-riding. Free-riding within the groups (for example, 
in CRGs) occurs when an individual obtains the benefit of joint authorship of a 
review without making a commensurate level of input. Other aspects of free-riding 
are people using the Cochrane badge to obtain funds or credibility for other purposes; 
and others to be peripherally involved in the work but still gain salaries or travel 
funds for ostensibly contributing to the product. The way in which these problems are 
managed depends on the CRG and may vary between them depending on their size, 
and characteristics such as the levels of social and human capital, ability to monitor 
individual input, conflict resolution mechanisms, and ability to impose sanctions. 
Discussion
We discuss the IAD analysis in four parts. In the first, we discuss the knowledge 
produced by Cochrane; in the second, we discuss Cochrane itself and the way in 
which the resource is managed; in the third, we discuss collective action problems 
of Cochrane; and in the last part we discuss some ways of strengthening Cochrane’s 
performance and sustainability. We conclude that Cochrane can profitably be viewed 
as a knowledge commons whose primary purpose is to produce and share knowledge 
through systematic reviews of health interventions. Cochrane produces this knowledge 
by group management of a complex mix of resources – social, human and financial – 
as common property. Because the resources are finite, rules, both formal and informal, 
govern access to the resource and the ways in which it is used, and influence the success 
and sustainability of the group effort. As a voluntary collective effort, Cochrane is 
subject to collective action problems that also influence its output and sustainability. 
Cochrane, now into its third decade, has made an important contribution to 
efforts to respond to the challenge set by Archie Cochrane. The organisation has 
grown from the bottom up, even if with a considerable public subsidy, and has now 
produced more than 7000 reviews, with a current production rate between 400 and 
500 systematic reviews per year.
The actual reviews, widely seen as definitive summaries of what is best practice 
based on knowledge to date, influence clinical and public health practice in many 
settings. Further, the methods and approaches developed by Cochrane since its 
inception are now widely used by individuals and groups in the development of 
policy and guidelines in both national and international organisations. Nevertheless, 
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the assessment indicates problems and issues and, in summary, we conclude that the 
continued success and sustainability of the Collaboration depends on addressing:
• Enduring problems with the knowledge output of Cochrane
• Management of the complex resource base 
• Collective action problems
The knowledge produced
The utility of the knowledge produced depends on the quality of the reviews, the 
extent to which they are widely accessible, and the permanence of the record.
Quantity and quality 
Cochrane led the way in systematic reviews of the effects of health interventions. 
The view from within and without Cochrane was that they had set new standards 
for the preparation of systematic reviews through provision of strict guidelines, and 
thus their work was less prone to bias. More than 20 years later there are many 
other sources of systematic reviews, although no other sources commit to updating. 
Some commentators and authors openly challenge Cochrane because of the variable 
quality of its reviews. At the same time, within the organisation there is ongoing 
dissatisfaction, from a range of sources, with the editorial process which is described 
as long and cumbersome. 
A search for reasons for the quality problems uncovers abundant anecdotal evidence 
that the workload of Co-ordinating Editors is heavy, with the result that protocols 
and draft reviews may sit for long periods at editorial base waiting for review and, 
hopefully, approval. Data from the CEU indicate that the median time at editorial 
base for protocol development is approximately nine months and for reviews is one 
year. These long waits result in long periods of time from initiation to publication 
– the median time is almost two years – with little indication that it is decreasing. 
Authors consistently rate delays at editorial base amongst their main complaints with 
the Cochrane system (Misso et al, 2017).
Thus, the factors contributing to the variable and persisting quality concerns are 
various, and many of them are structural rather than the result of the inadequate 
skills of authors. The dilemma for Cochrane is that its reputation is dependent on 
continuing to produce systematic reviews of high quality, even as quality is seen by 
many as the most important problem for Cochrane (Misso et al, 2017).
In response, in 2008 Cochrane appointed an EIC and, in 2012, a new CEO. 
Cochrane now has a central staff of approximately 50, ten times the number at the 
turn of the century. Nevertheless, an EIC, a CEO, and more than 40 new staff later, 
the quality problem continues.
There is an apparent reluctance on the part of the Central Executive and, perhaps, the 
CCSG to make the results of quality assessments public. There is a similar reluctance 
to make performance assessments of CRGs public and to withdraw the privileges of 
those who are not producing at an adequate standard. There is no ongoing systematic 
attempt to routinely survey quality or to understand what the problems are. Whilst 
there is a list of centrally sponsored activities aimed at improving quality they do not 
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appear to arise from a rigorous assessment of the problem or a coherent strategy for 
improvement.
Moves to more systematic surveillance of quality should go beyond reliance on 
journal impact factors to use of the more comprehensive approach to metrics discussed 
in the recent report by Wilsdon et al (2015).
Access 
The high ambition of universal OA to Cochrane reviews features in both the first 
and second strategy documents and in the Policy Manual (Cochrane Collaboration, 
2014): ‘We will achieve universal open access to Cochrane Systematic Reviews 
immediately upon publication for both new and updated reviews, and the archive 
of existing published reviews’ (2014, 112). However, the reality is quite different for 
potential users in many countries. Experience so far indicates that the predominant 
mode of publishing under the new model will be Green OA, with the result that many 
will not have access to new reviews for 12 months after publication, earlier versions 
of reviews will not be available at all, and ‘use’ is restricted because availability of the 
CC-BY licence itself is limited by the publishing agreement. Thus, expanding access 
and availability for other uses remains a crucial challenge for Cochrane. 
Permanence 
As in all scholarly publications, the system of references in a Cochrane Review 
links the current work to that which has gone before, the actual studies that form 
the input for a systematic review. The linked works represent the common pool of 
knowledge – the knowledge commons (Waters, 2011,146) – for that particular topic. 
It is vital that a reader can check the references if she wishes. Her ability to check 
the references depends on a ‘reliable, ongoing system for preserving the knowledge 
commons’.The Cochrane Library was digitised from its inception in 1993, when it 
was distributed on floppy disks, and subsequently online. As such it is subject to the 
issues of preservation that now confront all scholarly journals distributed online – as 
Waters (2011) writes: ‘This is the process of ensuring that the knowledge commons 
endures (Suber, 2011) – that scholarly materials are available for citation and, if cited, are 
available for consultation and further study’. The first issue is that digital materials are 
often less permanent than we assume. Thus, Klein et al (2014) assessed issues related to 
reference rot for more than one million citations in science, technology and medicine 
journals published between 1997 and 2012. They view reference rot as due to both 
link rot (the resource referenced no longer exists) and content rot (the content of the 
resource identified has changed over time). Twenty percent of articles suffered from 
some form of reference rot. Although there have been no similar assessments made 
for the Cochrane Library, the situation is likely to be similar. 
A long-term problem relates to the potential disappearance from the web of portals 
hosting journals from sale or failure of the journal. Some technical solutions to long-
term digital archiving are in development – these include tracking where digital 
journals are archived, and specialist sites to ensure that journal articles can be accessed 
even if the portals that host them disappear from the web. Furthermore, Green OA 
arrangements that allow authors to deposit their manuscripts in a public repository 
of their choice after 12 months not only expands the range of possible ways a review 
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may be accessed, but also increase the risk of a largely disseminated knowledge base 
across vulnerable portals and sites. Arrangements with these sites are vital to ensure 
that published work is available both now and in the future. 
We conclude that there is a problem with quality of the reviews and that addressing 
this problem is top priority for sustainability of Cochrane. The second priority, also 
important for sustainability, is to widen access to the reviews. And the third priority 
is to ensure that the record of knowledge produced by Cochrane is permanent. 
Managing the resource
In addressing these three priorities Cochrane will need to turn attention to its own 
attributes and processes, especially understanding the resource, the nature of the 
interactions in its own entities, and the production of public goods with emphasis 
on rules and governance. 
The task is to manage the resource to achieve the goal(s) in a sustainable manner. 
The resource for this knowledge commons is complex and relies to a significant 
extent on all three main sources – social capital, human capital and funds. The actual 
mix has probably varied significantly over time and with the nature of the task. Most 
information about the first decade of Cochrane, and particularly the early years, 
indicates that social capital was an important resource. There are some indications that 
the importance of social capital in the mix has been reduced in the second decade as 
the excitement, enthusiasm and commitment that marked the early years has waned. 
Some have argued that there is less social capital now than before and that the amount 
being created today is less. It is also possible that at the specific group level social 
capital is being built through interactions around specific tasks. 
Thus, whilst the role of social capital is agreed to be important, its role has not 
received explicit attention and measurement is difficult. Nevertheless, many believe that 
it remains an important resource component. If so, it will be important to continue 
to build social capital now.
Cochrane has been heavily reliant on human capital from the start, and continues 
to have access to highly qualified academic, technical and administrative staff, both in 
the various groups and at the central level in a range of countries. This is one of the 
most important resources for Cochrane. The extent to which this component of the 
resource is dependent on a certain level of social capital is thought to be significant 
but so far has received no attention in Cochrane. 
It is also important to remember that authors who publish in peer-reviewed journals 
do so without payment – what Suber (2011) describes as ‘author donation’. Their 
motivation for doing this is that they want their work to be ‘… noticed, read, taken 
up, built upon, applied, used and cited’. In addition, they use the journal’s time stamp 
to establish when the work was done, and they use this method of publication to 
advance their careers. Scholars can donate their journal articles because they are paid 
by universities and hospitals. Assessing Cochrane depends on understanding these 
underlying motivations. 
The category of personnel in shortest supply, relative to need, are the Co-ordinating 
Editors (CEs) – they are usually among the most senior and experienced people 
in their field, often have a heavy workload in their regular job, and usually bear 
responsibility for mentoring and supervising more junior staff working on CRs and 
for signing off on the protocols and reviews issuing from their group. There are some 
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indications that where this does not happen the quality of reviews is lower. Further, 
as CEs are usually the oldest group of Cochrane volunteers they are the ones most 
likely to leave due to retirement. Now is the time to start finding their replacements, 
to start succession planning. 
It is our observation that the CEs are frequently the point at which congestion in 
the editorial process occurs – they are also the people most likely to be able to ensure 
that younger participants have a positive experience. Recruiting more authors and 
more reviews will increase, rather than decrease, congestion at the CE level. On the 
other hand, support for the CE would potentially ease their workload, ease congestion, 
facilitate improved quality of reviews, allow identification of the next generation of 
CEs, and enable a smoother succession. 
Thus, managing the resource in all its complexity (social, human and financial) 
is critical to the sustainability of the Collaboration; failure to do so will lead to 
degradation of the resource and, ultimately, to reduced ability to meet its goals. 
Collective action problems
Like all group efforts, Cochrane is subject to the collective action problems of free-
riding, variable commitment, and under-supply of public goods, especially surveillance 
of its product, compliance with rules, and processes for dispute resolution. 
Improving quality, access and permanence requires attention to the internal 
processes of Cochrane, especially rules-in-use and overall governance, surveillance, 
and conflict resolution, all areas that appear to have been under-emphasised and 
under-provided in the past. Correcting this under-provision will be more likely if 
there is clear endorsement by the CCSG, and clear and deliberate support by the 
senior members of Cochrane. 
It seems clear that there is considerable variation between CRGs, and possibly 
groups of authors, in the rules-in-use during the production of CRs. Whilst the 
MECIR standards have been set, there is still considerable variation between groups 
in editorial process; this includes variation in the core rules-in-use by authors and 
CRGs. For example, only in 2017 is the organisation agreeing that reviews that do 
not meet basic quality criteria can be rejected, and yet by June 2017 the ‘rejection 
policy’ has not been agreed. The task now is for the CRGs and other entities to agree 
anew on the basic rules-in-use that should form the core of Cochrane processes in 
all CRGs as reviews are produced. Similar attention is required to identify the basic 
rules-in-use that govern processes at the CCSG level. It is vital that at all levels the 
emphasis is on transparency and accountability. 
Surveillance of quality and public disclosure of the results is critical to improving 
quality of the reviews. Systematic surveillance of quality has been missing from the 
Cochrane toolkit from the beginning. This, combined with the belief that they had 
the best quality in the business so there was no need for surveillance, meant that 
variation was not detected until after the event and, even then, there was no public 
disclosure of the results. Both surveillance and disclosure (and the discussion that, 
hopefully, ensues) are now needed if Cochrane is to justifiably reclaim the mantle of 
the highest quality systematic reviews. 
Public discussion of the results of such surveillance will mean that there are disputes 
and conflict over quality and the best way to improve it. It may require withdrawal 
of commission from some CRGs and CEs. There will then be a need for agreed 
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procedures for conflict resolution, something that has apparently also been missing 
from the Cochrane toolkit, probably because conflicts have mostly been avoided or 
dealt with in non-transparent ways in the past. 
Cochrane needs to look more closely at processes and interactions within its entities. 
These interactions are the crux of Cochrane activities, but little seems to be known 
about how these entities operate and the ways in which they might be strengthened. 
This will involve understanding the motivations of the members and the ways in 
which engagement of this volunteer force and the quality of their product can be 
improved and sustained. This understanding is essential to controlling free-riding and 
enhancing commitment. 
Finally, the Cochrane community will need to address the difference in interests 
between the volunteers who produce most of the output, and the salaried staff. 
The volunteers are motivated to produce reviews with the widest possible access 
and use, and have a strong interest in maintaining quality. Whilst they have interest 
in a publishing model that at least breaks even, their interest in a profit is much less 
marked. At the same time, the salaried staff necessarily have interest in a publishing 
model that turns a profit, at least sufficient to provide regular increases in salary, even 
if at the expense of access and future use. In addition, there are tensions between 
various constituent groups, for example Cochrane Centres, aiming to get authors in 
the region published, and CRGS, who, in recent years, may reject author teams if they 
do not seem to have the required skills to complete a review; or between software 
development teams aiming to produce next generation platforms and authors and 
editors struggling to complete high quality reviews using platforms with bugs that 
are not being fixed due to these other commitments. These fundamentally different 
interests need to be recognised, understood and, if possible, accommodated or resolved.
Running in parallel with differences in interests between volunteers and salaried 
staff is the issue of centralisation and decentralisation of Cochrane. It started as a very 
decentralised organisation with a small staff and a basic set of rules-in-use. Now, what 
are essentially commercial concerns, deriving from the business model and publishing 
agreement, are pushing Cochrane in the direction of more central staff and increased 
control from the centre. Whilst some movement in that direction may be required 
there is increased tension between the periphery (for instance, CRGs) and the centre 
as the search for future direction continues. Finding the balance between control 
by the centre, discretion at the periphery, and support for and from the producers is 
a critical and ongoing discussion for all organisations, including Cochrane, as they 
change, their environment changes, and their resources change as well. 
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1 http://community.cochrane.org/editorial-and-publishing-policy-resource/cochrane-
review-management/policy-withdrawing-published-cochrane-reviews-including-
protocols
2 http://community.cochrane.org/editorial-and-publishing-policy-resource/cochrane-
review-management/process-event-serious-errors-published-cochrane-reviews
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